Answer
Solu-Medrone (methylprednisolone sodium succinate) is indicated to treat acute exacerbations of multiple sclerosis superimposed on a relapsing-remitting background when a rapid and intense corticosteroid effect is required.
Sources for this answer
- Solu-Medrone 40mg for injectionPfizer Limited · emc · SmPC §4.1 Therapeutic Indications · Version 39Document updated
Sources checked